Study Stopped
PI left Indiana University and has elected not to continue this project at new institution.
Gene Expression Profiles in Healing and Non-Healing Wounds
GeneScreen
1 other identifier
observational
74
1 country
1
Brief Summary
The purpose of this study is to develop a database containing information about genes/proteins/fats as well as wound infections in both healing and non-healing wounds. Many wounds that do not heal are infected. This study will help us determine if there is a relationship between the types of infections and how well a wound heals. Identification of genes/proteins/lipids (fats) that help predict wound healing under specific wound healing conditions will enable health care practitioners to select more appropriate treatments, monitor the responses to those treatments, and figure out what standard treatments should be.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 8, 2010
CompletedFirst Posted
Study publicly available on registry
April 12, 2010
CompletedStudy Start
First participant enrolled
July 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2021
CompletedApril 25, 2024
February 1, 2024
1.2 years
April 8, 2010
April 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gene Expression Profiles
A database of gene/protein/lipid expression and wound infection in healing and non-healing wounds.
12 weeks
Secondary Outcomes (4)
Wound microbiome in healing and non-healing wounds
12 weeks
Wound area at baseline vs 12 weeks
12 weeks
Ultrasound images (per availability)
12 weeks
Histopathological analysis in healing vs non-healing wounds
12 weeks
Eligibility Criteria
Patients who have a chronic wound(s) (defined as a wound that has been present for at least 4 weeks).
You may qualify if:
- Age: 18 years and above
- Ulcer duration of \> 4 weeks
You may not qualify if:
- Pregnant females
- Receiving chemotherapy or radiation therapy for cancer
- Known or suspected malignancy of current study ulcer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IU Health Methodist Hospital
Indianapolis, Indiana, 46202, United States
Related Publications (19)
Meehan M, O'Hara L, Morrison YM. Report on the prevalence of skin ulcers in a home health agency population. Adv Wound Care. 1999 Nov-Dec;12(9):459-67.
PMID: 10687558BACKGROUNDPieper B, Templin TN, Dobal M, Jacox A. Wound prevalence, types, and treatments in home care. Adv Wound Care. 1999 Apr;12(3):117-26.
PMID: 10655791BACKGROUNDGottrup F, Holstein P, Jorgensen B, Lohmann M, Karlsmar T. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg. 2001 Jul;136(7):765-72. doi: 10.1001/archsurg.136.7.765.
PMID: 11448387BACKGROUNDCoerper S, Wicke C, Pfeffer F, Koveker G, Becker HD. Documentation of 7051 chronic wounds using a new computerized system within a network of wound care centers. Arch Surg. 2004 Mar;139(3):251-8. doi: 10.1001/archsurg.139.3.251.
PMID: 15006880BACKGROUNDKalani M, Brismar K, Fagrell B, Ostergren J, Jorneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care. 1999 Jan;22(1):147-51. doi: 10.2337/diacare.22.1.147.
PMID: 10333917BACKGROUNDGrolman RE, Wilkerson DK, Taylor J, Allinson P, Zatina MA. Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia. Am Surg. 2001 Nov;67(11):1072-9; discussion 1080.
PMID: 11730224BACKGROUNDMisuri A, Lucertini G, Nanni A, Viacava A, Belardi P. Predictive value of transcutaneous oximetry for selection of the amputation level. J Cardiovasc Surg (Torino). 2000 Feb;41(1):83-7.
PMID: 10836229BACKGROUNDNiinikoski J. Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making. Wound Repair Regen. 2003 Nov-Dec;11(6):458-61. doi: 10.1046/j.1524-475x.2003.11610.x.
PMID: 14617286BACKGROUNDPadberg FT, Back TL, Thompson PN, Hobson RW 2nd. Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischemic extremity. J Surg Res. 1996 Feb 1;60(2):365-9. doi: 10.1006/jsre.1996.0059.
PMID: 8598670BACKGROUNDGordillo GM, Schlanger R, Wallace WA, Bergdall V, Bartlett R, Sen CK. Protocols for topical and systemic oxygen treatments in wound healing. Methods Enzymol. 2004;381:575-85. doi: 10.1016/S0076-6879(04)81037-1. No abstract available.
PMID: 15063699BACKGROUNDPatterson JA, Bennett RG. Prevention and treatment of pressure sores. J Am Geriatr Soc. 1995 Aug;43(8):919-27. doi: 10.1111/j.1532-5415.1995.tb05538.x. No abstract available.
PMID: 7636103BACKGROUNDRoy S, Rink C, Khanna S, Phillips C, Bagchi D, Bagchi M, Sen CK. Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement. Gene Expr. 2004;11(5-6):251-62. doi: 10.3727/000000003783992289.
PMID: 15200237BACKGROUNDRoy S, Khanna S, Wallace WA, Lappalainen J, Rink C, Cardounel AJ, Zweier JL, Sen CK. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J Biol Chem. 2003 Nov 21;278(47):47129-35. doi: 10.1074/jbc.M308703200. Epub 2003 Sep 2.
PMID: 12952964BACKGROUNDRoy S, Lado BH, Khanna S, Sen CK. Vitamin E sensitive genes in the developing rat fetal brain: a high-density oligonucleotide microarray analysis. FEBS Lett. 2002 Oct 23;530(1-3):17-23. doi: 10.1016/s0014-5793(02)03309-4.
PMID: 12387859BACKGROUNDRoy S, Khanna S, Bentley K, Beffrey P, Sen CK. Functional genomics: high-density oligonucleotide arrays. Methods Enzymol. 2002;353:487-97. doi: 10.1016/s0076-6879(02)53071-8. No abstract available.
PMID: 12078521BACKGROUNDLiu-Stratton Y, Roy S, Sen CK. DNA microarray technology in nutraceutical and food safety. Toxicol Lett. 2004 Apr 15;150(1):29-42. doi: 10.1016/j.toxlet.2003.08.009.
PMID: 15068823BACKGROUNDEisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8. doi: 10.1073/pnas.95.25.14863.
PMID: 9843981BACKGROUNDPawitan Y, Michiels S, Koscielny S, Gusnanto A, Ploner A. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics. 2005 Jul 1;21(13):3017-24. doi: 10.1093/bioinformatics/bti448. Epub 2005 Apr 19.
PMID: 15840707BACKGROUNDEfron B, Tibshirani R, Storey JD, Tusher V. Empirical Bayes Analysis of a Microarray Experiment. Journal of the American Statistical Association. 2001; 96(456):1151-1160.
BACKGROUND
Biospecimen
Tissue
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Gayle Gordillo, MD
Indiana University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 8, 2010
First Posted
April 12, 2010
Study Start
July 30, 2020
Primary Completion
October 23, 2021
Study Completion
October 23, 2021
Last Updated
April 25, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share